Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Golpanian

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of the American College of Cardiology|October 31, 2015
Synergistic Effects of Combined Cell Therapy for Chronic Ischemic CardiomyopathyVasileios Karantalis, Viky Y Suncion-Loescher, Luiza Bagno, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 27, 2017
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging FrailtySamuel Golpanian, Darcy L DiFede, Aisha Khan, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 5, 2017
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical TrialBryon A Tompkins, Darcy L DiFede, Aisha Khan, et al.
Journal of the American College of Cardiology|November 19, 2016
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM TrialJoshua M Hare, Darcy L DiFede, Angela C Rieger, et al.
Circulation Research|September 20, 2017
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)Victoria Florea, Angela C Rieger, Darcy L DiFede, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of the American College of Cardiology|October 31, 2015
Synergistic Effects of Combined Cell Therapy for Chronic Ischemic CardiomyopathyVasileios Karantalis, Viky Y Suncion-Loescher, Luiza Bagno, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 27, 2017
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging FrailtySamuel Golpanian, Darcy L DiFede, Aisha Khan, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 5, 2017
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical TrialBryon A Tompkins, Darcy L DiFede, Aisha Khan, et al.
Journal of the American College of Cardiology|November 19, 2016
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM TrialJoshua M Hare, Darcy L DiFede, Angela C Rieger, et al.
Circulation Research|September 20, 2017
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)Victoria Florea, Angela C Rieger, Darcy L DiFede, et al.
Pageof 3